RxSight, Inc. RXST

What this company does

RxSight, Inc. is a commercial-stage medical technology company that provides customized vision to patients following cataract surgery. Its RxSight system comprises the RxSight Light Adjustable Lens and the RxSight Light Delivery Device, along with related accessories. As of December 31, 2025, the company had 461 full-time employees. The company manufactures, assembles, tests and ships its LAL and LDD products at a campus of five facilities in Aliso Viejo, California, totaling approximately 150,000 square feet. As of December 31, 2025, it had an installed base of 1,134 LDDs in ophthalmology practices, and surgeons had implanted approximately 300,000 LALs since its inception. Its RxSight system has regulatory approval in the U.S., Europe, Canada, Mexico, Singapore, Australia and South Korea. In the U.S., it primarily sells its LAL products to ambulatory surgical centers, and occasionally to hospitals. The company was incorporated in California on March 5, 1997 as Calhoun Vision, Inc., changed its name to RxSight, Inc. in October 2016, and reincorporated in Delaware on July 6, 2021.

Written from the business description in RxSight, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.